C4 THERAPEUTICS INC
CCCC · NASDAQ
Updated at 2026-10-15 08:07:21
- Today's High
- $2.79
- Today’s Low
- $2.59
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $2.72
- Previous Close
- $2.61
- Volume
- 3.09M
- Market Cap
- $321.09M
- P/E Ratio
- --
- EPS
- $-0.99
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 490 ARSENAL WAY, WATERTOWN, MA, UNITED STATES, 02472
- Country
- US
- Listing Date
- 2020-10-02
- Fiscal Year End
- December
- Shares Outstanding
- 110.57M
- CIK
- 0001662579
- Website
- c4therapeutics.com
C4 Therapeutics, Inc., a biopharmaceutical company, develops new therapeutic candidates to target and destroy disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. The company is headquartered in Watertown, Massachusetts.
Financial Metrics
Revenue
2026-06-30
$6.64M
2026-03-31
$6.15M
2025-12-31
$11.01M
2025-09-30
$11.23M
Operating Expenses
2026-06-30
$33.06M
2026-03-31
$32.13M
2025-12-31
$34.16M
2025-09-30
$45.64M
Net Income
2026-06-30
-$23.63M
2026-03-31
-$25.12M
2025-12-31
-$20.48M
2025-09-30
-$32.16M
Net Profit Margin
2026-06-30
-355.89%
2026-03-31
-408.46%
2025-12-31
-185.96%
2025-09-30
-286.42%
Earnings Per Share
2026-06-30
$-0.18
2026-03-31
$-0.20
2025-12-31
$-0.18
2025-09-30
$-0.30
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$23.34M
2026-03-31
-$24.72M
2025-12-31
-$19.93M
2025-09-30
-$31.7M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
-0.59%
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $6.64M | $6.15M | $11.01M | $11.23M |
| Operating Expenses | $33.06M | $32.13M | $34.16M | $45.64M |
| Net Income | -$23.63M | -$25.12M | -$20.48M | -$32.16M |
| Net Profit Margin | -355.89% | -408.46% | -185.96% | -286.42% |
| Earnings Per Share | $-0.18 | $-0.20 | $-0.18 | $-0.30 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$23.34M | -$24.72M | -$19.93M | -$31.7M |
| Effective Tax Rate | -- | -- | -0.59% | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.